| | | 69398 | | 15.10.2025 | | Vertex Pharmaceuticals (CH) GmbH | | | | | | | 14.10.2030 | | | | | | 03.99. | | | | 03.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Alyftrek 4 mg/ 20 mg/ 50 mg | Filmtabletten | Coated tablets (Vanzacaftorum 4 mg, Tezacaftorum 20 mg, Deutivacaftorum 50 mg) | R07AX33 | CI | | 02 | Alyftrek 10 mg/ 50 mg/ 125 mg | Filmtabletten | Coated tablets (Vanzacaftorum 10 mg, Tezacaftorum 50 mg, Deutivacaftorum 125 mg) | R07AX33 | CI |
|
|
